AURA
Price
$7.12
Change
+$0.17 (+2.45%)
Updated
Jul 17 closing price
Capitalization
441.47M
20 days until earnings call
VRDN
Price
$17.05
Change
+$0.26 (+1.55%)
Updated
Jul 17 closing price
Capitalization
1.39B
19 days until earnings call
Interact to see
Advertisement

AURA vs VRDN

Header iconAURA vs VRDN Comparison
Open Charts AURA vs VRDNBanner chart's image
Aura Biosciences
Price$7.12
Change+$0.17 (+2.45%)
Volume$176.35K
Capitalization441.47M
Viridian Therapeutics
Price$17.05
Change+$0.26 (+1.55%)
Volume$419.24K
Capitalization1.39B
AURA vs VRDN Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. VRDN commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and VRDN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (AURA: $7.12 vs. VRDN: $17.05)
Brand notoriety: AURA and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 79% vs. VRDN: 56%
Market capitalization -- AURA: $441.47M vs. VRDN: $1.39B
AURA [@Biotechnology] is valued at $441.47M. VRDN’s [@Biotechnology] market capitalization is $1.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while VRDN’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 3 bearish.
  • VRDN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AURA is a better buy in the short-term than VRDN.

Price Growth

AURA (@Biotechnology) experienced а +5.17% price change this week, while VRDN (@Biotechnology) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +40.41%.

Reported Earning Dates

AURA is expected to report earnings on Nov 06, 2025.

VRDN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.39B) has a higher market cap than AURA($441M). VRDN YTD gains are higher at: -11.059 vs. AURA (-13.382). AURA has higher annual earnings (EBITDA): -101.63M vs. VRDN (-304.76M). VRDN has more cash in the bank: 637M vs. AURA (128M). AURA has less debt than VRDN: AURA (18.4M) vs VRDN (21.2M). VRDN has higher revenues than AURA: VRDN (302K) vs AURA (0).
AURAVRDNAURA / VRDN
Capitalization441M1.39B32%
EBITDA-101.63M-304.76M33%
Gain YTD-13.382-11.059121%
P/E RatioN/AN/A-
Revenue0302K-
Total Cash128M637M20%
Total Debt18.4M21.2M87%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAVRDN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MYINX9.060.02
+0.22%
NYLI WMC International Rsrch Eq Inv Cl
FICVX36.79N/A
N/A
Fidelity Advisor Convertible Secs I
SMFCX28.51N/A
N/A
American Beacon Stephens Mid-Cap Gr C
RFISX17.07N/A
N/A
Ranger Small Cap Institutional
CSZIX17.87N/A
N/A
Cohen & Steers Real Estate Securities Z